Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
LivaNova updates 2021 guidance
LivaNova updated its 2021 outlook, expecting full-year worldwide net sales from continuing operations to grow 5 to 10 percent on a constant-currency basis and adjusted diluted earnings per share to be $1.60 to $1.90.
2021
LivaNova appoints Alex Shvartsburg CFO
LivaNova announced the appointment of Alex Shvartsburg as chief financial officer, effective August 1. He had served as interim CFO since October 31, 2020.
2021
LivaNova reports second-quarter 2021 results
LivaNova reported second-quarter 2021 results, including worldwide sales from continuing operations of $264.5 million.
2021
LivaNova completes initial closing of heart valve business divestiture
LivaNova announced that it completed the initial closing of the divestiture of its heart valve business to Gyrus Capital for €60 million ($73 million); Corcym will manage the business.
2020
LivaNova announces proposed $250 million notes offering
LivaNova announced its intention to offer $250 million in aggregate principal amount of cash exchangeable senior notes due 2025 through its U.S. subsidiary, subject to market conditions and other factors.